Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline ; volume:9 ; number:1 ; day:29 ; month:12 ; year:2017 ; pages:1-10 ; date:12.2017
Alzheimer's research & therapy ; 9, Heft 1 (29.12.2017), 1-10, 12.2017
- Schlagwort
-
Demenz
Rückenmarkskrankheit
Bewegungsstörung
Gedächtnisstörung
Basalganglienkrankheit
Lewy-Körperchen-Demenz
- Urheber
-
Bos, Isabelle
- Beteiligte Personen und Organisationen
-
Verhey, Frans R.
Ramakers, Inez H.G.B
Jacobs, Heidi I. L.
Soininen, Hilkka
Freund-Levi, Yvonne
Hampel, Harald
Tsolaki, Magda
Wallin, Åsa K.
van Buchem, Mark A.
Oleksik, Ania
Verbeek, Marcel M.
Olde Rikkert, Marcel
van der Flier, Wiesje M.
Scheltens, Philip
Aalten, Pauline
Visser, Pieter Jelle
Vos, Stephanie J. B.
SpringerLink (Online service)
- DOI
-
10.1186/s13195-017-0328-9
- URN
-
urn:nbn:de:1111-2018022310376
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bos, Isabelle
- Verhey, Frans R.
- Ramakers, Inez H.G.B
- Jacobs, Heidi I. L.
- Soininen, Hilkka
- Freund-Levi, Yvonne
- Hampel, Harald
- Tsolaki, Magda
- Wallin, Åsa K.
- van Buchem, Mark A.
- Oleksik, Ania
- Verbeek, Marcel M.
- Olde Rikkert, Marcel
- van der Flier, Wiesje M.
- Scheltens, Philip
- Aalten, Pauline
- Visser, Pieter Jelle
- Vos, Stephanie J. B.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
The “rights” of precision drug development for Alzheimer’s disease
Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks
Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum
Steeper memory decline after COVID-19 lockdown measures
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
The “rights” of precision drug development for Alzheimer’s disease
Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks
Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum
Steeper memory decline after COVID-19 lockdown measures
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
The “rights” of precision drug development for Alzheimer’s disease
Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks
Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum
Steeper memory decline after COVID-19 lockdown measures